(c) 2024 PillSync.com

efavirenz emtricitabine and tenofovir disoproxil fumarate tablet film coated

1 INDICATIONS & USAGE Efavirenz, emtricitabine and tenofovir disoproxil fumarate tablet is indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg. Efavirenz, emtricitabine and tenofovir disoproxil fumarate tablets is a three-drug combination of efavirenz (EFV), a nonnucleoside reverse transcriptase inhibitor, and emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF), both HIV-1 nucleoside analog reverse transcriptase inhibitors, and is indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg. ( 1 )

macleods pharmaceuticals limited


8 months ago OVAL PINK CL81 efavirenz emtricitabine and tenofovir disoproxil fumarate tablet film coated

OVAL PINK CL81

8 months ago OVAL PINK CL81 efavirenz emtricitabine and tenofovir disoproxil fumarate tablet film coated

CL81 OVAL PINK

16 HOW SUPPLIED/STORAGE AND HANDLING

EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets are pink, capsule shaped,biconvex,film coated debossed with “CL81” on one side and plain faced on the other side. Bottle of 30 NDC 33342-138-07 Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature] • Keep container tightly closed. • Dispense only in original container.


More pills like OVAL CL81












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site